In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Co-Promotes: A Marketplace Reality, But Do They Make Sense?

Executive Summary

Co-promotions are a hallmark of today's licensing deals as biotechs try to secure their future growth. But do they make sense--for the product, or for the partners?
Advertisement

Related Content

Actelion Follows Innovation into GP Markets
Approval Delays for J&J/Basilea's Ceftobiprole Shake Partnership
Europe's New Spec Pharma Models
The Heyday of Biotech Dealmaking
CEO Interview: AstraZeneca's David Brennan
How Often are Co-Promotion Options Actually Exercised?
NicOx's Naproxcinod: Hitting the NSAID Sweet Spot?
Share the Wealth? No Thanks
Cytokinetics Stays the Course
The Anti-Global, Specialist Strategy: Why Bayer's Choice Might Be Right for Other Pharmas

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

IV002924

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel